TY - GEN
T1 - Investigations into thermally mediated drug delivery using a preclinical system for MRI-guided focused ultrasound
AU - Staruch, Robert
AU - Chopra, Rajiv
AU - Hynynen, Kullervo
PY - 2011
Y1 - 2011
N2 - The objective of this research was to investigate the use of a preclinical system for MRI-guided focused ultrasound to achieve MRI-controlled hyperthermia and thermally-mediated drug delivery in vivo. Here we report results from ten rabbits, where a focused xultrasound (FUS) beam was scanned in a circular trajectory to heat 10-15 mm diameter regions in normal thigh to 43°C for 20-30 minutes. MRI thermometry was used for closed-loop feedback control to achieve temporally and spatially uniform heating. Lyso-thermosensitive pegylated liposomal doxorubicin (ThermoDox®, Celsion Corporation, Columbia, MD) was infused intravenously during hyperthermia, and the tissue doxorubicin concentration was measured by the fluorescence intensity of homogenized tissue samples from heated and unheated thigh, obtained 2 hours after heating. Closed-loop control of FUS hyperthermia using MRI thermometry achieved temperature distributions with mean, T90 and T10 of 42.9°C, 41.0°C and 44.8°C across the 10 mm diameter target, varying ±0.9°C (SD) over 20 min. Drug concentrations in heated regions were, on average 15.3 ± 8.1 (SD) times higher than in the unheated contralateral thigh. The results show the feasibility of using MRI-controlled FUS hyperthermia for preclinical studies of thermally mediated drug delivery with temperature-sensitive liposomes.
AB - The objective of this research was to investigate the use of a preclinical system for MRI-guided focused ultrasound to achieve MRI-controlled hyperthermia and thermally-mediated drug delivery in vivo. Here we report results from ten rabbits, where a focused xultrasound (FUS) beam was scanned in a circular trajectory to heat 10-15 mm diameter regions in normal thigh to 43°C for 20-30 minutes. MRI thermometry was used for closed-loop feedback control to achieve temporally and spatially uniform heating. Lyso-thermosensitive pegylated liposomal doxorubicin (ThermoDox®, Celsion Corporation, Columbia, MD) was infused intravenously during hyperthermia, and the tissue doxorubicin concentration was measured by the fluorescence intensity of homogenized tissue samples from heated and unheated thigh, obtained 2 hours after heating. Closed-loop control of FUS hyperthermia using MRI thermometry achieved temperature distributions with mean, T90 and T10 of 42.9°C, 41.0°C and 44.8°C across the 10 mm diameter target, varying ±0.9°C (SD) over 20 min. Drug concentrations in heated regions were, on average 15.3 ± 8.1 (SD) times higher than in the unheated contralateral thigh. The results show the feasibility of using MRI-controlled FUS hyperthermia for preclinical studies of thermally mediated drug delivery with temperature-sensitive liposomes.
KW - Focused ultrasound
KW - Liposomes
KW - MRI thermometry
KW - Targeted drug delivery
UR - http://www.scopus.com/inward/record.url?scp=80053647106&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053647106&partnerID=8YFLogxK
U2 - 10.1063/1.3607899
DO - 10.1063/1.3607899
M3 - Conference contribution
AN - SCOPUS:80053647106
SN - 9780735409170
T3 - AIP Conference Proceedings
SP - 163
EP - 167
BT - 10th International Symposium on Therapeutic Ultrasound, ISTU 2010
T2 - 10th International Symposium on Therapeutic Ultrasound, ISTU 2010
Y2 - 9 June 2010 through 12 June 2010
ER -